Connect with us

Technology

Stowers Institute partners with Google DeepMind and leading research institutions to help reveal the regulatory language of the human genome

Published

on

Researchers provided biological expertise and feedback that helped guide the development of a new AI-powered resource released today. For the first time, scientists can explore a comprehensive map of more than 9 billion possible single-letter DNA changes through a web browser, helping them more quickly prioritize and interpret variants that may influence biology and disease and lay groundwork for future treatments. 

KEY HIGHLIGHTS 

Developed over several years, AlphaGenome Atlas is a one-petabyte dataset containing molecular-effect predictions for more than 9 billion possible single-letter DNA changes across the human genome.Until now, researchers lacked a single resource that could both rank variants across the genome and reveal the biological processes they are predicted to disrupt, a combination that could accelerate foundational discoveries, disease research and the search for therapeutic targets.Researchers from Google DeepMind, the Stowers Institute for Medical Research, Broad Institute, the University of Exeter, Memorial Sloan Kettering Cancer Center and Stanford University contributed scientific input and explored applications of the resource.

KANSAS CITY, Mo., Sept. 8, 2026 /PRNewswire/ — The human genome contains approximately 3 billion DNA letters, creating more than 9 billion possible single-letter changes. Testing the effects of each change in a laboratory would be practically impossible. Google DeepMind’s new AlphaGenome Atlas, available beginning today, gives scientists a comprehensive, searchable resource designed to accelerate understanding of the human genome.

The one-petabyte resource contains artificial intelligence-generated predictions for the molecular effects of more than 9 billion possible changes, creating what Google DeepMind describes as the most comprehensive catalogue of its kind.

Stowers Institute for Medical Research Investigator Julia Zeitlinger, Ph.D., partnered with the Google DeepMind team led by Vice President of Science and Chief Scientist Žiga Avsec, Ph.D., to map and interpret the patterns in DNA that regulate biological processes inside cells. At the same time, additional scientific collaborators from leading institutions across the United States and England helped test how the new resource could be used to identify impactful genetic variation in humans. The work is now available as a preprint on bioRxV. 

Zeitlinger has made significant contributions to the field of gene regulation and computational biology. In 2019, in an international collaboration that included Avsec, Zeitlinger and her team at the Stowers Institute developed a powerful AI framework, BPNet. This framework is now widely used to extract and dissect the DNA sequences that explain genome-wide biological data. Just last month, her lab unveiled a new AI method, PISA, which generates high-resolution visualizations of what AI models have learned from DNA. 

Stowers Institute Bioinformatics Scientist and Zeitlinger Lab member, Melanie Weilert, served as a lead author on the AlphaGenome project. With her deep expertise in interpretating AI models, she helped build the AlphaGenome Atlas resource to ask one of biology’s biggest questions: How does a cell know which genes to turn on and off?

“This is a very difficult problem because every cell type speaks a slightly different language, making it hard to know which rules are general,” Zeitlinger said. “With AlphaGenome, we can quickly query many cell types and look for general patterns by which genes are activated and repressed.”

Google DeepMind developed the technology behind the Atlas. Zeitlinger, who also leads the Stowers Institute’s AI Initiative, helped connect its predictions to the biological processes that give cells their identities and allow them to function.

“AlphaGenome Atlas is a powerful example of how AI can expand human knowledge and advance scientific discovery,” said VP Science, Google DeepMind and Chief Scientist, Google Cloud, Pushmeet Kohli, Ph.D. “By making this resource widely available, we hope scientists around the world can use it to better understand the language of life and what happens when individual letters in the human genome change.”

Scientists can access the resource through a web browser without writing code, allowing more researchers to explore genetic variation at a scale that was not previously possible.

“AlphaGenome Atlas is foundational research with the potential to have an impact across multiple areas of biology,” said Avsec. “We worked with experts in the field, including Julia, whose biological insight helped us explore how the resource can map functional elements in the genome and reveal their roles at the molecular level.” 

How Stowers scientists helped reveal the regulatory “words” of the genome

Every cell in the human body contains essentially the same DNA, yet different cells use that information in very different ways. Short DNA sequences called motifs act as regulatory instructions, helping control which genes are active, when they are activated and how strongly they operate.

Zeitlinger and her team used AlphaGenome Atlas to analyze regulatory motifs across the genome and determine what they reveal about the proteins, called transcription factors, that control gene activity. The researchers categorized these regulatory signals by function, distinguishing transcription factors that change whether DNA is accessible from those that also activate or repress genes.

Conducting this type of analysis experimentally across thousands of sites and many different cell types would require enormous time and resources. By making genome-wide predictions available in one searchable resource, the Atlas allowed Zeitlinger’s team to identify broader patterns in how genes are regulated and begin defining the general rules underlying the regulatory language of DNA.

“Having these motifs mapped at base-pair resolution across the genome and in many cell types gives us a searchable dictionary for non-coding DNA,” Zeitlinger said. “By giving the scientific community access to these predictions, AlphaGenome Atlas can accelerate how we identify potentially disease-causing variants while helping us understand the fundamental rules by which genes are regulated.”

“This collaboration demonstrates how Stowers scientists are helping shape emerging technologies, not simply adopting them,” said Stowers Institute President and Chief Scientific Officer Alejandro Sánchez Alvarado, Ph.D. “By pairing deep biological knowledge with the capabilities of AI, researchers can ask questions at a scale that was not previously possible and create new opportunities to more clearly understand human health and disease.”

The Atlas does not replace laboratory research. Instead, it can help scientists determine which variants and biological mechanisms should be investigated first, focusing experimental time and resources on the most promising questions.

“Tools such as AlphaGenome Atlas become most valuable when their predictions can be connected to meaningful biological questions,” said Stowers Institute Scientific Director Kausik Si, Ph.D. “Julia’s work brings together deep expertise in gene regulation and computational biology to help move us from simply reading DNA sequence toward understanding the rules that control gene activity.”

From billions of variants to focused biological questions 

AlphaGenome Atlas contains thousands of molecular-effect predictions for each variant across hundreds of human cell types and tissues. These predictions contribute to the new AlphaGenome Variant Impact, or AVI, score. They also enabled researchers to identify and map recurring DNA motifs, short sequences where transcription factors bind to help control gene activity.

The AVI score brings together predictions from AlphaGenome, AlphaMissense and evolutionary conservation data. It gives researchers a single measure for ranking variants by their potential impact across protein-coding and non-coding regions of the genome. Researchers can then examine which molecular processes, including gene expression, RNA splicing and protein function, are predicted to be affected.

The collaborating institutions explored how the resource could support several areas of human genetic research. Scientists at the Broad Institute used the AVI score to prioritize a previously overlooked non-coding variant associated with an unsolved rare disease case. At the University of Exeter, researchers applied Atlas to genomic data from more than 54,000 UK Biobank participants, uncovering additional associations between rare noncoding variants and protein levels. 

Watch a video from Google DeepMind and read a blog post announcing AlphaGenome Atlas.

Learn more and watch a tutorial of AlphaGenome Atlas 

AlphaGenome Atlas is available for non-commercial use through Google DeepMind’s website at deepmind.google.com/science/alphagenome/atlas. Its predictions are intended to support research and have not been validated or approved for clinical use.

About the Stowers Institute for Medical Research 

Founded in 1994 through the generosity of Jim Stowers, founder of American Century Investments, and his wife, Virginia, the Stowers Institute for Medical Research is a nonprofit, biomedical research organization with a focus on foundational research. Its mission is to expand our understanding of the secrets of life and improve life’s quality through innovative approaches to the causes, treatment, and prevention of diseases.

The Institute consists of 24 independent research programs. Of the approximately 500 members, over 370 are scientific staff that include principal investigators, fellows, technology center directors, postdoctoral scientists, graduate students, and technical support staff. Learn more about the Institute at stowers.org and about its graduate program at stowers.org/gradschool. 

Read an online version of the release here. 

Media contact 

Joe Chiodo 
Director of Communications 
Stowers Institute for Medical Research 
724-462-8529 
chiodo.joe@stowers.org 

View original content to download multimedia:https://www.prnewswire.com/news-releases/stowers-institute-partners-with-google-deepmind-and-leading-research-institutions-to-help-reveal-the-regulatory-language-of-the-human-genome-302872938.html

SOURCE Stowers Institute for Medical Research

Continue Reading

Technology

Agenda for the 4th Hong Kong Clinical-driven Robotics and Embodied AI Technology (CREATE) Symposium Officially Released

Published

on

By

Leading Experts from Medicine, Research, Industry and Investment Revealed

HONG KONG, Sept. 11, 2026 /PRNewswire/ — Scheduled for September 22–23, 2026, the 4th Hong Kong Clinical-driven Robotics and Embodied AI Technology (CREATE) Symposium will be held at the Charles K. Kao Auditorium in Hong Kong Science Park. The Centre for Artificial Intelligence and Robotics (CAIR), Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences (CAS), organizes the event, with co-organization by the Hong Kong Science and Technology Parks Corporation (HKSTP).

The CREATE Symposium is dedicated to building a platform for in-depth dialogue between clinical medicine and cutting-edge technology. Having been held successfully for multiple editions, it has become a flagship international symposium on embodied intelligence in healthcare. This year’s event will focus on the practical clinical needs of more than ten specialties, including neurology, neurosurgery, respiratory intervention, otolaryngology, ultrasound imaging, and sleep medicine. It will bring together world-leading academicians, hospital directors, department leaders, and innovative scholars at the intersection of medicine and engineering to explore clinical applications and translation pathways of AI and robotics technologies, accelerating innovation and industrialization in global healthcare technology.

Symposium Highlights

This year’s symposium features a special “Hospital Presidents’ Roundtable” session. Eight hospital leaders from the Greater Bay Area will engage in in-depth discussions on integrating medicine and engineering, smart hospital development, and practical applications of medical AI.

The distinguished panel includes:

Linbo CAI, President of Guangdong 999 Brain Hospital, Chief Physician, and Doctoral Supervisor at Jinan University.

Kenneth Man-Chee CHEUNG, President and Hospital Chief Executive of The University of Hong Kong – Shenzhen Hospital, The Jessie Ho Professor in Spine Surgery and Chair Professor, Department of Orthopedics and Traumatology, HKU.

Kin-lai CHUNG, CEO of The Chinese University of Hong Kong (CUHK) Medical Centre.

Xiquan HU, Director, Management Committee of Lingnan Hospital; Director and Chief Physician, Department of Rehabilitation Medicine, The Third Affiliated Hospital, Sun Yat-sen University; President-Elect, Chinese Society of Physical Medicine and Rehabilitation, Chinese Medical Association.

Lijian JIN, Dean of Faculty of Dentistry, Modern Dental Group Professor in Clinical Dental Science, HKU.

Wing-yee SO, Hospital Chief Executive of North District Hospital, Hospital Authority.

Kenneth Hing Lim TSANG, Regional CEO of IHH Healthcare North Asia, CEO of Gleneagles Hospital Hong Kong.

Yi XIONG, Executive Director of Shenzhen Luohu District People’s Hospital.

The symposium will also launch CARES 4.0, a multi-modal medical AI large model and intelligent agent system for healthcare scenarios. Concurrently, a dedicated MedTech innovation exhibition will showcase cutting-edge medical hardware, AI algorithms, and other innovative achievements, demonstrating the latest capabilities in embodied intelligent healthcare.

As a co-organizer of this year’s symposium, HKSTP will host a special session titled “Empowering Founders, Enabling Growth: HKSTP’s Entrepreneurship Journey from Idea to Commercialization”. The session will introduce HKSTP’s life and health technology ecosystem and startup community, share The Road to Commercialization: Insights and Success Stories from HKSTP Startups, and feature the Roundtable Discussion: Empowering Value Creation and Growth through Strategic Partnerships.

Notably, the CREATE Symposium will debut a new “Roadshow Session” on September 23. The session will connect top-tier investment institutions with innovative companies. Participating companies will showcase products and technologies while receiving professional feedback from leading investors.

Investors from renowned institutions including Guangyuan Investment, Jiuguang Capital, Allwinner Technology, Yuexiu Group, Yanghe Investment, CICC Capital, Jianyuan Tianhua etc. have been invited to serve as judges. Invitations are also being extended to institutions such as Shenzhen Angel Fund of Funds, CCB International etc.

This year’s symposium will fully integrate MEDLing, CAIR’s proprietary intelligent conference assistant. The system has been customized and optimized for medical terminology, providing real-time speech transcription in Mandarin, English, and Cantonese, as well as high-precision transcript recording and simultaneous translation throughout the event. This will enable attendees from diverse fields and countries to communicate seamlessly and enjoy an enhanced conference experience.

Conference Information

Date: September 22–23, 2026 (Tuesday–Wednesday)
Venue: Charles K. Kao Auditorium, Hong Kong Science Park
Event Details and Latest Schedule: https://www.cair-cas.org.hk/article/662
Registration Link: https://forms.office.com/r/ePnu6HMySU?origin=lprLink

This year’s symposium features a dedicated healthcare technology exhibition area in the Atrium Link of Hong Kong Science Park. During the event, multiple guided tours will be organized to facilitate exchanges among attendees, academic experts, and industry representatives, fostering in-depth cross-sector collaboration.

Currently, only a limited number of booths remain available in the corporate exhibition area. Interested companies are invited to review partnership options

View original content:https://www.prnewswire.com/apac/news-releases/agenda-for-the-4th-hong-kong-clinical-driven-robotics-and-embodied-ai-technology-create-symposium-officially-released-302876370.html

SOURCE Centre for Artificial Intelligence and Robotics (CAIR), Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences

Continue Reading

Technology

Scholarship America Marks 25th Anniversary of 9/11 by Honoring Its Support for the Families of Freedom Scholarship Fund

Published

on

By

NEW YORK, Sept. 11, 2026 /PRNewswire/ — Scholarship America today marks the 25th anniversary of the Families of Freedom Scholarship Fund, which it established and has administered since the fund’s founding in the direct aftermath of the September 11th attacks.

On September 11, 2001, the unthinkable happened, and the nation was forever changed. Thousands of children, including those of Ground Zero first responders, lost a parent or watched one become permanently disabled. In response, Scholarship America helped establish the Families of Freedom Fund to protect the dreams of these students, which it has proudly administered for more than two decades.

In the years since, the Fund’s scope has expanded to include the children of rescue and rebuilding workers who developed long-term and chronic illnesses tied to their service, nearly doubling the number of students eligible for support. Meeting that growing need has required an equally significant response: more than 20,000 individuals, corporations, foundations, and organizations – including longtime supporters Citi and Strada Education Foundation – have contributed to the Fund, helping award $193 million to 3,877 students who lost a parent or had one permanently disabled as a result of the September 11th attacks and the recovery efforts that followed.

“From the moment the horrific attacks unfolded, we knew the impact would echo across generations,” said Brandee McHale, Head of Community Investing and Development at Citi and President of the Citi Foundation. “We are proud of the work we did with organizations across the country to create this Fund, making a lasting commitment to support the educational needs of the children of victims.”

The Fund’s commitment will carry through 2030, when its youngest beneficiaries complete their undergraduate education.

“Twenty-five years later, we still remember how this Fund began—born out of one of the worst days in our nation’s history in an effort to ensure that these victims’ children wouldn’t lose their futures along with their loved ones,” said Mike Nylund, President and CEO of Scholarship America. “A promise was made to these students, and Scholarship America has been honored to help keep it for the past twenty-five years. Watching them graduate, build careers, and give back to their own communities has been one of the great privileges of this organization’s history.  On behalf of every student this Fund has supported, I am incredibly grateful for the generosity that made it possible.”

About Scholarship America

Since 1958, Scholarship America has been committed to breaking down financial barriers to higher education, turning the generosity of donors into life-changing opportunities for students across the country. To date, the organization has distributed more than $6 billion in scholarships to over 3.5 million students, making it the nation’s leading nonprofit scholarship administrator. Scholarship America also partners with individuals, foundations, small businesses, and nearly half of today’s Fortune 500 companies to deliver end-to-end scholarship program management for students pursuing degrees and certifications at technical, vocational, and two- and four-year colleges and universities.

Contacts:

Claire Berge Schmidt
Scholarship America
cbergeschmidt@scholarshipamerica.org

Logan Flynn
Hiltzik Strategies
lflynn@hstrategies.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/scholarship-america-marks-25th-anniversary-of-911-by-honoring-its-support-for-the-families-of-freedom-scholarship-fund-302875885.html

SOURCE Scholarship America

Continue Reading

Technology

The 26th CIFIT Opens in Xiamen, Merchants from 129 Countries and Regions Seek Business Opportunities

Published

on

By

XIAMEN, China, Sept. 11, 2026 /PRNewswire/ — A report from IQINGDAO:

The 26th China International Fair for Investment and Trade (CIFIT) opened in Xiamen on September 8. More than 1,200 government agencies and business delegations from 129 countries and regions as well as 30 international organizations gathered at the event to explore opportunities for two‑way investment and cooperation.

As a landmark platform for “Invest in China”, this year’s CIFIT revolves around three major sections: “Invest in China”, “Chinese Investment” and “International Investment”. For the first time, it features Finland and Saudi Arabia as dual Guest Countries of Honor, and Guangdong and Qinghai as dual Guest Provinces of Honor.

Both the exhibition area and the number of exhibitors in the financial zone have doubled at this edition. A special zone for the Cross‑border Interbank Payment System (CIPS) makes its debut at CIFIT. A new special zone for new quality productive forces has been set up, focusing on cutting‑edge sectors including artificial intelligence and low‑altitude economy.

Over 40 key investment‑promotion events will be held during the fair, alongside nearly 100 supporting activities such as capital matchmaking and special‑topic roadshows. The Online CIFIT platform pools resources including investment‑attraction projects, corporate financing and industrial funds. Empowered by digital technologies, it enables easier project sourcing and more efficient capital matching.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/the-26th-cifit-opens-in-xiamen-merchants-from-129-countries-and-regions-seek-business-opportunities-302876390.html

SOURCE Iqingdao

Continue Reading

Trending